Search Results 481-490 of 24135 for B cell lymphomas

  1. Innovative therapies shape the future of chronic lymphocytic leukemia treatment - Mayo Clinic

    BTK inhibitors work by blocking the B-cell receptor signaling pathway. Then in 2016, the FDA approved the first B-cell lymphoma 2 (BCL-2) inhibitor drug for the ...

  2. Publications - Jess F. Peterson, M.D. - Mayo Clinic

    Large B-cell lymphoma with IRF4 gene rearrangements: Differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult ...

  3. Cancer Physicians - Medical Professionals - Mayo Clinic

    Marginal zone lymphoma, B-cell lymphoma, Lymphoma, Hairy cell leukemia, T-cell lymphoma, Small lymphocytic lymphoma, Follicular lymphoma, Hodgkin lymphoma ...

  4. Hematology - Clinical trials

    This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...

  5. Cancer Physicians - Medical Professionals - Mayo Clinic

    Marginal zone lymphoma, B-cell lymphoma, Lymphoma, Hairy cell leukemia, T-cell lymphoma, Small lymphocytic lymphoma, Follicular lymphoma, Hodgkin lymphoma ...

  6. Cutaneous T-cell lymphoma - Doctors and departments - Mayo Clinic

    Mayo Clinic doctors and scientists are studying ways to improve the diagnosis and treatment of cutaneous T-cell lymphoma. Cancer research is conducted in ...

  7. A Study to Provide Access to CTL019 Out of Specification Managed Access Program (MAP) for ALL or DLBCL Patients - Mayo Clinic

    ... b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial ...

  8. Clinical trials - Oncology (Medical)

    1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...

  9. Clinical trials - Oncology (Medical)

    The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell malignancies ...

  10. Clinical trials - Oncology (Medical)

    Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Pagination Clinical studies. PrevPrevious ...